Company Monitoring Page for Sarepta

latest headlines for company on cafepharma

Sarepta Is Undervalued Even Without Eteplirsen Accelerated Approval
TheStreet.com
Tue, 03/5/13 - 11:51 am
Tags:
Sarepta, eteplirsen
4 Can't-Miss Health-Care Events This Week
Motley Fool
Mon, 03/4/13 - 10:46 am
Tags:
Depomed, FDA, Serada, Breo Ellipta, COPD, GSK, Theravance, Aegerion, Sarepta
Why Sarepta Therapeutics Shares Shot Higher
Motley Fool
Wed, 02/27/13 - 05:25 pm
Tags:
Sarepta, Duchenne Muscular Dystrophy, eteplirsen
Sarepta May Seek Partnership Advice for Experimental Drug
Bloomberg
Fri, 01/11/13 - 12:12 pm
Tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
4 Biotech Stocks With Insider Interest
Motley Fool
Thu, 01/10/13 - 11:30 am
Tags:
Infinity Pharmaceuticals, Merrimack Pharmaceuticals, Sarepta, Arena Pharmaceuticals
JPMorgan Healthcare Conference Highlights: Sarepta Therapeutics
Motley Fool
Thu, 01/10/13 - 11:27 am
Tags:
JPMHC 2013, Sarepta
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Tags:
Eisai, Sarepta, Arena Pharmaceuticals, Amarin, Gilead, Biomarin, Onyx, Medivation, Achillion, Incyte, Cell Therapeutics, Celgene, NPS Pharmaceuticals, Aegerion, Roche, Biogen Idec, Ariad Pharmaceuticals, Alexza, Navidea, Aveo
Sarepta CEO: $125 Million Offering Demand Was Strong
TheStreet.com
Thu, 12/13/12 - 04:30 pm
Tags:
Sarepta, Chris Garabedian
Small-Cap Biotechs That Could Make Big Moves This Week
Seeking Alpha
Mon, 12/10/12 - 12:06 pm
Tags:
Star Scientific, Acadia, Alexza, Santarus, Sarepta, Ariad Pharmaceuticals
Sarepta Is Still A Buy: Recent Concerns Much Ado About Nothing
TheStreet.com
Mon, 12/10/12 - 11:31 am
Tags:
Sarepta, Duchenne Muscular Dystrophy, eteplirsen
Another Unbelievable Month for Sarepta
Motley Fool
Fri, 12/7/12 - 11:44 am
Tags:
Sarepta
1 Event That Could Make or Break Biotech Stocks
Motley Fool
Thu, 12/6/12 - 10:50 am
Tags:
Halozyme, Isis Pharmaceuticals, Biomarin, Bristol-Myers Squibb, Sarepta
The Road Toward Far-Reaching Therapeutics Through Illumina, Sarepta
Seeking Alpha
Tue, 12/4/12 - 01:36 pm
Tags:
Sarepta, Illumina, Life Technologies, Exelixis
Will Sarepta Receive Accelerated Approval?
Motley Fool
Sat, 12/1/12 - 09:25 am
Tags:
Sarepta, eteplirsen, muscular dystrophy, Duchenne Muscular Dystrophy
Is NeuralStem The Next Sarepta?
Seeking Alpha
Wed, 11/28/12 - 10:52 am
Tags:
Sarepta, Neuralstem
10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook
TheStreet.com
Tue, 11/27/12 - 11:12 am
Tags:
Affymax, Pharmacyclics, Galena Biopharma, Threshold Pharmaceuticals, Hemispherx Biopharma, Sunesis, Celsion, Sarepta, Arena Pharmaceuticals, BioDelivery Sciences
Several Biopharmas That Look Ready For Upside Gains
Yahoo/Reuters
Tue, 11/20/12 - 01:18 pm
Tags:
Sarepta, BG Medicine, Amicus, Santarus, Celldex
Sarepta Ready To Move Higher
Seeking Alpha
Tue, 11/20/12 - 11:35 am
Tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
Sarepta climbs after analyst says competitor delay removes overhang
Yahoo/Fly on the Wall
Mon, 11/12/12 - 11:25 am
Tags:
Sarepta, DispersinB, GSK, Prosensa, Duchenne Muscular Dystrophy, eteplirsen
Sarepta Presents 48-Week Data For Duchenne's Drug At World Muscle Society Congress
Seeking Alpha
Wed, 10/17/12 - 11:19 am
Tags:
Sarepta, Duchenne Muscular Dystrophy, eteplirsen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.